Treatment of renal cell carcinoma with systemic administration of intermediate doses of recombinant human interleukin-2 alone. Recombinant Human Interleukin-2 (S-6820) Research Group on Renal Cell Carcinoma
-
- Aso
- 作成者
収録刊行物
-
- Prog. Clin. Biol. Res.
-
Prog. Clin. Biol. Res. 303 681-, 1989
詳細情報
-
- CRID
- 1370851343941248640
-
- データソース種別
-
- Crossref